Aneuploid Cell Survival Relies upon Sphingolipid Homeostasis
Open Access
- 1 October 2017
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (19) , 5272-5286
Abstract
Aneuploidy, a hallmark of cancer cells, poses an appealing opportunity for cancer treatment and prevention strategies. Using a cell-based screen to identify small molecules that could selectively kill aneuploid cells, we identified the compound N-[2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]-decanamide monohydrochloride (DL-PDMP), an antagonist of UDP-glucose ceramide glucosyltransferase. DL-PDMP selectively inhibited proliferation of aneuploid primary mouse embryonic fibroblasts and aneuploid colorectal cancer cells. Its selective cytotoxic effects were based on further accentuating the elevated levels of ceramide, which characterize aneuploid cells, leading to increased apoptosis. We observed that DL-PDMP could also enhance the cytotoxic effects of paclitaxel, a standard-of-care chemotherapeutic agent that causes aneuploidy, in human colon cancer and mouse lymphoma cells. Our results offer pharmacologic evidence that the aneuploid state in cancer cells can be targeted selectively for therapeutic purposes, or for reducing the toxicity of taxane-based drug regimens. Cancer Res; 77(19); 5272–86. ©2017 AACR.Keywords
All Related Versions
This publication has 57 references indexed in Scilit:
- Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cellsMolecular Systems Biology, 2012
- Chromosomal instability and aneuploidy in cancer: from yeast to manEMBO Reports, 2012
- Identification of Aneuploidy-Selective Antiproliferation CompoundsCell, 2011
- A mammalian functional-genetic approach to characterizing cancer therapeuticsNature Chemical Biology, 2010
- Identification of Aneuploidy-Tolerating MutationsCell, 2010
- Colorectal cancerThe Lancet, 2010
- Integrative approach for prioritizing cancer genes in sporadic colon cancerGenes, Chromosomes and Cancer, 2009
- Principles of Cancer Therapy: Oncogene and Non-oncogene AddictionCell, 2009
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995
- Serine Palmitoyltransferase Is the Primary Target of a Sphingosine-like Immunosuppressant, ISP-1/MyriocinBiochemical and Biophysical Research Communications, 1995